Literature DB >> 31536116

Parents' Self-efficacy for Tobacco Exposure Protection and Smoking Abstinence Mediate Treatment Effects on Child Cotinine at 12-Month Follow-up: Mediation Results from the Kids Safe and Smokefree Trial.

Bradley N Collins1, Stephen J Lepore1, Jonathan P Winickoff2, David W Sosnowski3.   

Abstract

INTRODUCTION: Compared with the general smoking population, low-income smokers face elevated challenges to success in evidence-based smoking cessation treatment. Moreover, their children bear increased disease burden. Understanding behavioral mechanisms related to successful reduction of child tobacco smoke exposure (TSE) could inform future smoking interventions in vulnerable, underserved populations.
METHODS: Smoking parents were recruited from pediatric clinics in low-income communities and randomized into a multilevel intervention including a pediatric clinic intervention framed in best clinical practice guidelines ("Ask, Advise, Refer" [AAR]) plus individualized telephone counseling (AAR + counseling), or AAR + control. Mediation analysis included treatment condition (independent variable), 12-month child cotinine (TSE biomarker, criterion), and four mediators: 3-month end-of-treatment self-efficacy to protect children from TSE and smoking urge coping skills, and 12-month perceived program (intra-treatment) support and bioverified smoking abstinence. Analyses controlled for baseline nicotine dependence, depressive symptoms, child age, and presence of other residential smokers.
RESULTS: Participants (n = 327) included 83% women and 83% African Americans. Multilevel AAR + counseling was associated with significantly higher levels of all four mediators (ps < .05). Baseline nicotine dependence (p < .05), 3-month self-efficacy (p < .05) and 12-month bioverified smoking abstinence (p < .001) related significantly to 12-month child cotinine outcome. The indirect effects of AAR + counseling intervention on cotinine via self-efficacy for child TSE protection and smoking abstinence (ps < .05) suggested mediation through these pathways.
CONCLUSIONS: Compared with AAR + control, multilevel AAR + counseling improved all putative mediators. Findings suggest that fostering TSE protection self-efficacy during intervention and encouraging parental smoking abstinence may be key to promoting long-term child TSE-reduction in populations of smokers with elevated challenges to quitting smoking. IMPLICATIONS: Pediatric harm reduction interventions to protect children of smokers from tobacco smoke have emerged to address tobacco-related health disparities in underserved populations. Low-income smokers experience greater tobacco-related disease burden and more difficulty with smoking behavior change in standard evidence-based interventions than the general population of smokers. Therefore, improving knowledge about putative behavioral mechanisms of smoking behavior change that results in lower child exposure risk could inform future intervention improvements. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco 2019.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31536116      PMCID: PMC7593366          DOI: 10.1093/ntr/ntz175

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  35 in total

1.  How does coping help people resist lapses during smoking cessation?

Authors:  Kathleen A O'Connell; Vanessa L Hosein; Joseph E Schwartz; Ruth Q Leibowitz
Journal:  Health Psychol       Date:  2007-01       Impact factor: 4.267

Review 2.  Parental smoking cessation to protect young children: a systematic review and meta-analysis.

Authors:  Laura J Rosen; Michal Ben Noach; Jonathan P Winickoff; Mel F Hovell
Journal:  Pediatrics       Date:  2011-12-26       Impact factor: 7.124

3.  An Office-Initiated Multilevel Intervention for Tobacco Smoke Exposure: A Randomized Trial.

Authors:  Bradley N Collins; Stephen J Lepore; Jonathan P Winickoff; Uma S Nair; Beth Moughan; Tyra Bryant-Stephens; Adam Davey; Daniel Taylor; David Fleece; Melissa Godfrey
Journal:  Pediatrics       Date:  2018-01       Impact factor: 7.124

4.  Self-efficacy: toward a unifying theory of behavioral change.

Authors:  A Bandura
Journal:  Psychol Rev       Date:  1977-03       Impact factor: 8.934

5.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

6.  Health promotion by social cognitive means.

Authors:  Albert Bandura
Journal:  Health Educ Behav       Date:  2004-04

Review 7.  A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report.

Authors: 
Journal:  Am J Prev Med       Date:  2008-08       Impact factor: 5.043

8.  Clinical Practice Policy to Protect Children From Tobacco, Nicotine, and Tobacco Smoke.

Authors:  Harold J Farber; Susan C Walley; Judith A Groner; Kevin E Nelson
Journal:  Pediatrics       Date:  2015-11       Impact factor: 7.124

9.  Babies Living Safe & Smokefree: randomized controlled trial of a multilevel multimodal behavioral intervention to reduce low-income children's tobacco smoke exposure.

Authors:  Bradley N Collins; Stephen J Lepore
Journal:  BMC Public Health       Date:  2017-03-14       Impact factor: 3.295

10.  Kids Safe and Smokefree (KiSS): a randomized controlled trial of a multilevel intervention to reduce secondhand tobacco smoke exposure in children.

Authors:  Stephen J Lepore; Jonathan P Winickoff; Beth Moughan; Tyra C Bryant-Stephens; Daniel R Taylor; David Fleece; Adam Davey; Uma S Nair; Melissa Godfrey; Bradley N Collins
Journal:  BMC Public Health       Date:  2013-08-30       Impact factor: 3.295

View more
  1 in total

1.  A Parental Smoking Cessation Intervention in the Pediatric Emergency Setting: A Randomized Trial.

Authors:  E Melinda Mahabee-Gittens; Robert T Ammerman; Jane C Khoury; Meredith E Tabangin; Lili Ding; Ashley L Merianos; Lara Stone; Judith S Gordon
Journal:  Int J Environ Res Public Health       Date:  2020-11-04       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.